In:
Pulmonary Circulation, Wiley, Vol. 9, No. 3 ( 2019-07), p. 1-3
Kurzfassung:
The Breelib™ nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 µg using Breelib™ caused significant improvements in invasively measured afterload and cardiac index but not echocardiographic right ventricular strain during 30 min post‐inhalation.
Materialart:
Online-Ressource
ISSN:
2045-8940
,
2045-8940
DOI:
10.1177/2045894019875342
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2019
ZDB Id:
2638089-4